146 related articles for article (PubMed ID: 12005211)
1. Study of therapy resistance in cancer cells with functional proteome analysis.
Poland J; Schadendorf D; Lage H; Schnölzer M; Celis JE; Sinha P
Clin Chem Lab Med; 2002 Mar; 40(3):221-34. PubMed ID: 12005211
[TBL] [Abstract][Full Text] [Related]
2. Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells.
Stein U; Lage H; Jordan A; Walther W; Bates SE; Litman T; Hohenberger P; Dietel M
Int J Cancer; 2002 Feb; 97(6):751-60. PubMed ID: 11857350
[TBL] [Abstract][Full Text] [Related]
3. Association of genomic imbalances with drug resistance and thermoresistance in human gastric carcinoma cells.
Tönnies H; Poland J; Sinha P; Lage H
Int J Cancer; 2003 Mar; 103(6):752-8. PubMed ID: 12516094
[TBL] [Abstract][Full Text] [Related]
4. Selection and characterization of heat-resistant variants of multidrug-resistant human gastric carcinoma cell lines.
Jordan A; Scholz R
Exp Oncol; 2005 Mar; 27(1):18-23. PubMed ID: 15812352
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of annexin I and thioredoxin detected by two-dimensional gel electrophoresis of drug resistant human stomach cancer cells.
Sinha P; Hütter G; Köttgen E; Dietel M; Schadendorf D; Lage H
J Biochem Biophys Methods; 1998 Nov; 37(3):105-16. PubMed ID: 9870185
[TBL] [Abstract][Full Text] [Related]
6. Human melanoma cell lines selected in vitro displaying various levels of drug resistance against cisplatin, fotemustine, vindesine or etoposide: modulation of proto-oncogene expression.
Kern MA; Helmbach H; Artuc M; Karmann D; Jurgovsky K; Schadendorf D
Anticancer Res; 1997; 17(6D):4359-70. PubMed ID: 9494534
[TBL] [Abstract][Full Text] [Related]
7. Modulation of the atypical multidrug-resistant phenotype by a hammerhead ribozyme directed against the ABC transporter BCRP/MXR/ABCG2.
Kowalski P; Stein U; Scheffer GL; Lage H
Cancer Gene Ther; 2002 Jul; 9(7):579-86. PubMed ID: 12082458
[TBL] [Abstract][Full Text] [Related]
8. Molecular analysis of therapy resistance in gastric cancer.
Lage H
Dig Dis; 2003; 21(4):326-38. PubMed ID: 14752223
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the differential protein expression associated with thermoresistance in human gastric carcinoma cell lines.
Sinha P; Poland J; Schnölzer M; Celis JE; Lage H
Electrophoresis; 2001 Aug; 22(14):2990-3000. PubMed ID: 11565793
[TBL] [Abstract][Full Text] [Related]
10. High antineoplastic activity of new heterocyclic compounds in cancer cells with resistance against classical DNA topoisomerase II-targeting drugs.
Lage H; Aki-Sener E; Yalcin I
Int J Cancer; 2006 Jul; 119(1):213-20. PubMed ID: 16450374
[TBL] [Abstract][Full Text] [Related]
11. Study of the development of thermoresistance in human pancreatic carcinoma cell lines using proteome analysis.
Poland J; Urbani A; Lage H; Schnölzer M; Sinha P
Electrophoresis; 2004 Jan; 25(1):173-83. PubMed ID: 14730581
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel proteins associated with the development of chemoresistance in malignant melanoma using two-dimensional electrophoresis.
Sinha P; Kohl S; Fischer J; Hütter G; Kern M; Köttgen E; Dietel M; Lage H; Schnölzer M; Schadendorf D
Electrophoresis; 2000 Aug; 21(14):3048-57. PubMed ID: 11001322
[TBL] [Abstract][Full Text] [Related]
13. Enhanced expression of human ABC-transporter tap is associated with cellular resistance to mitoxantrone.
Lage H; Perlitz C; Abele R; Tampé R; Dietel M; Schadendorf D; Sinha P
FEBS Lett; 2001 Aug; 503(2-3):179-84. PubMed ID: 11513878
[TBL] [Abstract][Full Text] [Related]
14. Study of the development of chemoresistance in melanoma cell lines using proteome analysis.
Sinha P; Poland J; Kohl S; Schnölzer M; Helmbach H; Hütter G; Lage H; Schadendorf D
Electrophoresis; 2003 Jul; 24(14):2386-404. PubMed ID: 12874874
[TBL] [Abstract][Full Text] [Related]
15. Transcriptome analysis of different multidrug-resistant gastric carcinoma cells.
Heim S; Lage H
In Vivo; 2005; 19(3):583-90. PubMed ID: 15875780
[TBL] [Abstract][Full Text] [Related]
16. Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines.
Ross DD; Yang W; Abruzzo LV; Dalton WS; Schneider E; Lage H; Dietel M; Greenberger L; Cole SP; Doyle LA
J Natl Cancer Inst; 1999 Mar; 91(5):429-33. PubMed ID: 10070941
[TBL] [Abstract][Full Text] [Related]
17. Thermosensitivity of multidrug-resistant human gastric and pancreatic carcinoma cells.
Lage H; Jordan A; Scholz R; Dietel M
Int J Hyperthermia; 2000; 16(4):291-303. PubMed ID: 10949126
[TBL] [Abstract][Full Text] [Related]
18. Complete reversal of ABCG2-depending atypical multidrug resistance by RNA interference in human carcinoma cells.
Priebsch A; Rompe F; Tönnies H; Kowalski P; Surowiak P; Stege A; Materna V; Lage H
Oligonucleotides; 2006; 16(3):263-74. PubMed ID: 16978089
[TBL] [Abstract][Full Text] [Related]
19. Proteome analysis of multidrug resistance in vincristine-resistant human gastric cancer cell line SGC7901/VCR.
Yang YX; Xiao ZQ; Chen ZC; Zhang GY; Yi H; Zhang PF; Li JL; Zhu G
Proteomics; 2006 Mar; 6(6):2009-21. PubMed ID: 16525997
[TBL] [Abstract][Full Text] [Related]
20. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]